Primary |
Drug Use For Unknown Indication |
34.8% |
Product Used For Unknown Indication |
15.0% |
Depression |
11.9% |
Epilepsy |
7.6% |
Anxiety |
5.6% |
Hypertension |
4.8% |
Insomnia |
3.9% |
Pain |
2.8% |
Bipolar Disorder |
1.9% |
Schizophrenia |
1.8% |
Sleep Disorder Therapy |
1.6% |
Convulsion |
1.3% |
Dizziness |
1.1% |
Panic Disorder |
1.0% |
Intentional Self-injury |
1.0% |
Panic Attack |
0.9% |
Agitation |
0.8% |
Sleep Disorder |
0.8% |
Psychotic Disorder |
0.7% |
Fibromyalgia |
0.7% |
|
Somnolence |
15.3% |
Sopor |
7.6% |
Withdrawal Syndrome |
7.4% |
Vomiting |
7.1% |
Suicide Attempt |
6.8% |
Tremor |
6.5% |
Syncope |
6.3% |
Weight Decreased |
5.2% |
Weight Increased |
4.4% |
Overdose |
4.1% |
Tachycardia |
3.8% |
Death |
3.5% |
Insomnia |
3.3% |
Sudden Death |
3.3% |
Toxicity To Various Agents |
3.0% |
Epilepsy |
2.7% |
Drug Interaction |
2.5% |
Malaise |
2.5% |
Poisoning |
2.5% |
Pregnancy |
2.5% |
|
Secondary |
Drug Use For Unknown Indication |
18.4% |
Product Used For Unknown Indication |
16.7% |
Epilepsy |
9.7% |
Depression |
9.5% |
Hypertension |
4.9% |
Pain |
4.7% |
Insomnia |
4.6% |
Bipolar I Disorder |
4.4% |
Anxiety |
4.4% |
Parkinson's Disease |
3.4% |
Schizophrenia |
3.0% |
Bipolar Disorder |
2.9% |
Drug Exposure During Pregnancy |
2.9% |
Psychotic Disorder |
2.1% |
Constipation |
1.7% |
Neuralgia |
1.7% |
Convulsion |
1.4% |
Dizziness |
1.3% |
Trigeminal Neuralgia |
1.2% |
Sleep Disorder |
1.2% |
|
Somnolence |
18.6% |
Weight Increased |
8.1% |
Suicide Attempt |
7.9% |
Withdrawal Syndrome |
7.9% |
Vomiting |
6.8% |
Sopor |
6.4% |
Weight Decreased |
5.6% |
Tachycardia |
4.5% |
Self Injurious Behaviour |
4.3% |
Tremor |
4.1% |
Overdose |
3.1% |
White Blood Cell Count Increased |
3.1% |
Drug Ineffective |
2.9% |
Sudden Death |
2.9% |
Thrombocytopenia |
2.5% |
Vertigo |
2.5% |
Death |
2.3% |
Insomnia |
2.1% |
Renal Failure Acute |
2.1% |
Therapeutic Response Decreased |
2.1% |
|
Concomitant |
Product Used For Unknown Indication |
17.6% |
Drug Use For Unknown Indication |
13.3% |
Depression |
10.8% |
Epilepsy |
8.4% |
Hypertension |
8.2% |
Pain |
5.0% |
Anxiety |
4.4% |
Insomnia |
4.3% |
Rheumatoid Arthritis |
3.5% |
Schizophrenia |
3.4% |
Prophylaxis |
3.1% |
Parkinson's Disease |
3.0% |
Bipolar Disorder |
2.5% |
Sleep Disorder |
2.2% |
Osteoporosis |
2.1% |
Multiple Sclerosis |
1.9% |
Convulsion |
1.8% |
Diabetes Mellitus |
1.7% |
Constipation |
1.6% |
Relapsing-remitting Multiple Sclerosis |
1.2% |
|
Weight Increased |
13.2% |
Weight Decreased |
12.6% |
Vomiting |
11.2% |
Somnolence |
6.9% |
Tremor |
6.7% |
Pyrexia |
5.0% |
Thrombocytopenia |
4.6% |
Urinary Tract Infection |
4.0% |
Vision Blurred |
3.5% |
Suicide Attempt |
3.4% |
Toxic Skin Eruption |
3.3% |
Death |
3.2% |
Overdose |
3.1% |
Syncope |
3.1% |
Pneumonia |
3.0% |
Tachycardia |
2.8% |
Wrong Technique In Drug Usage Process |
2.8% |
Suicidal Ideation |
2.7% |
White Blood Cell Count Decreased |
2.6% |
Nervousness |
2.3% |
|
Interacting |
Drug Use For Unknown Indication |
26.7% |
Epilepsy |
10.4% |
Depression |
9.3% |
Product Used For Unknown Indication |
7.4% |
Aggression |
5.2% |
Anxiety |
4.8% |
Pain |
4.8% |
Agitation |
4.4% |
Insomnia |
4.4% |
Constipation |
3.3% |
Myocardial Infarction |
3.0% |
Dementia |
2.2% |
Hallucination |
2.2% |
Asthma |
1.9% |
Atrial Fibrillation |
1.9% |
Delirium |
1.9% |
Schizophrenia |
1.9% |
Bipolar I Disorder |
1.5% |
Fibromyalgia |
1.5% |
Hypertension |
1.5% |
|
Withdrawal Syndrome |
17.6% |
Somnolence |
15.7% |
Vomiting |
7.8% |
Drug Interaction |
5.9% |
Rhabdomyolysis |
5.9% |
Insomnia |
3.9% |
Malaise |
3.9% |
Muscular Weakness |
3.9% |
Pneumonia Aspiration |
3.9% |
Speech Disorder |
3.9% |
Sudden Death |
3.9% |
Suicide Attempt |
3.9% |
Tremor |
3.9% |
Wound |
3.9% |
Abdominal Pain |
2.0% |
Abortion Spontaneous |
2.0% |
Altered State Of Consciousness |
2.0% |
Drug Abuse |
2.0% |
Drug Exposure During Pregnancy |
2.0% |
Haemodialysis |
2.0% |
|